Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 18.86 is 36% below its 5-year average of 29.52, near the low end of its 5-year range (17.14–118.91).
As of the fiscal period ended Tuesday, June 30, 2026. 7.65% below its 12-month average of 20.42.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 18.86.
CURRENT RATIO
18.86
CURRENT RATIO AVG TTM
20.42
CURRENT RATIO AVG 3Y
25.97
CURRENT RATIO AVG 5Y
29.52
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.65%
CURRENT VS 3Y AVG
-27.36%
CURRENT VS 5Y AVG
-36.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.39
median of 611 covered companies
CURRENT VS SECTOR MEDIAN
+456.41%
vs the sector median at left
Design Therapeutics, Inc.
Market Cap
$748.55M
Current Ratio
18.86
TTM Avg
20.42
3Y Avg
25.97
5Y Avg
29.52
Market Cap
$747.00M
Current Ratio
9.39
TTM Avg
11.79
3Y Avg
11.79
5Y Avg
11.79
Market Cap
$744.51M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
Market Cap
$743.96M
Current Ratio
16.09
TTM Avg
8.04
3Y Avg
7.87
5Y Avg
9.13
Market Cap
$765.35M
Current Ratio
2.07
TTM Avg
1.18
3Y Avg
1.89
5Y Avg
3.24
Market Cap
$770.68M
Current Ratio
13.37
TTM Avg
5.16
3Y Avg
5.50
5Y Avg
4.90
Market Cap
$723.83M
Current Ratio
19.31
TTM Avg
14.05
3Y Avg
7.67
5Y Avg
5.91
Market Cap
$713.62M
Current Ratio
0.95
TTM Avg
4.92
3Y Avg
2.98
5Y Avg
5.72
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $748.55M | 18.86 | 20.42 | 25.97 | 29.52 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $747.00M | 9.39 | 11.79 | 11.79 | 11.79 |
| Cytek Biosciences, Inc. (CTKB)vs › | $744.51M | 4.48 | 5.45 | 6.78 | 8.00 |
| Candel Therapeutics, Inc. (CADL)vs › | $743.96M | 16.09 | 8.04 | 7.87 | 9.13 |
| Mesa Laboratories, Inc. (MLAB)vs › | $765.35M | 2.07 | 1.18 | 1.89 | 3.24 |
| Geron Corporation (GERN)vs › | $769.83M | 6.92 | 5.11 | 3.93 | 4.38 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | 13.37 | 5.16 | 5.50 | 4.90 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $723.83M | 19.31 | 14.05 | 7.67 | 5.91 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $713.62M | 0.95 | 4.92 | 2.98 | 5.72 |
| AdaptHealth Corp. (AHCO)vs › | $789.11M | 1.12 | 1.18 | 1.21 | 1.17 |
Current Ratio
18.86
Quick Ratio
18.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 18.86 |
| 2026-03-31 | 22.28 |
| 2025-12-31 | 17.14 |
| 2025-09-30 | 18.71 |
| 2025-06-30 | 25.13 |
| 2025-03-31 | 28.37 |
| 2024-12-31 | 29.31 |
| 2024-09-30 | 34.61 |
| 2024-06-30 | 41.42 |
| 2024-03-31 | 38.61 |
| 2023-12-31 | 29.58 |
| 2023-09-30 | 23.77 |
| 2023-06-30 | 25.22 |
| 2023-03-31 | 35.25 |
| 2022-12-31 | 31.10 |
| 2022-09-30 | 33.47 |
| 2022-06-30 | 48.96 |
| 2022-03-31 | 68.22 |
| 2021-12-31 | 72.96 |
| 2021-09-30 | 71.81 |
| 2021-06-30 | 118.91 |
| 2021-03-31 | 111.10 |
| 2020-12-31 | 15.55 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
